These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
450 related items for PubMed ID: 24488882
1. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up. Sultana F, English DR, Simpson JA, Canfell K, Gertig DM, Saville M. Int J Cancer; 2014 Sep 01; 135(5):1213-9. PubMed ID: 24488882 [Abstract] [Full Text] [Related]
2. Risk of CIN2 in women with a pap test without endocervical cells vs. those with a negative pap test with endocervical cells: a cohort study with 4.5 years of follow-up. Giorgi Rossi P, Baiocchi D, Ciatto S, Endocervical Cell Italian Working Group of Cervical Cancer Screening Group. Acta Cytol; 2010 Sep 01; 54(3):265-71. PubMed ID: 20518409 [Abstract] [Full Text] [Related]
3. Loss to follow-up of cervical smears without endocervical columnar cells is not disturbing. Tacken MA, Braspenning JC, Mulder J, Hermens RP, Nelen WL, de Bakker DH, Grol RP. Eur J Gynaecol Oncol; 2006 Sep 01; 27(1):42-6. PubMed ID: 16550967 [Abstract] [Full Text] [Related]
10. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia. Nygård JF, Nygård M, Skare GB, Thoresen SO. Acta Cytol; 2006 Sep 01; 50(3):295-302. PubMed ID: 16780024 [Abstract] [Full Text] [Related]
11. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia. Liao SY, Stanbridge EJ. Cancer; 2000 Mar 01; 88(5):1108-21. PubMed ID: 10699902 [Abstract] [Full Text] [Related]
12. Cervical cancer screening with liquid cytology in women with developmental disabilities. Kavoussi SK, Smith YR, Ernst SD, Quint EH. J Womens Health (Larchmt); 2009 Mar 01; 18(1):115-8. PubMed ID: 19072727 [Abstract] [Full Text] [Related]
13. The value of endocervical curettage during large loop excision of the transformation zone in combination with endocervical surgical margin in predicting persistent/recurrent dysplasia of the uterine cervix: a retrospective study. Scherer-Quenzer AC, Findeis J, Herbert SL, Yokendren N, Reinhold AK, Schlaiss T, Wöckel A, Diessner J, Kiesel M. BMC Womens Health; 2024 Aug 21; 24(1):461. PubMed ID: 39169335 [Abstract] [Full Text] [Related]
17. Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program. Thipsanthiah K, Kamsa-Ard S, Musika W, Teemuangsai W, Hawlader MDH. Asian Pac J Cancer Prev; 2023 Oct 01; 24(10):3429-3436. PubMed ID: 37898847 [Abstract] [Full Text] [Related]
19. Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy. Alqabbani R, Chan J, Goldberg A. Am J Clin Pathol; 2024 Apr 03; 161(4):369-373. PubMed ID: 38035727 [Abstract] [Full Text] [Related]